These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 26231117)
41. Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. Guo X; Liang Y; Zhang Y; Lasorella A; Kee BL; Fu YX Immunity; 2015 Apr; 42(4):731-43. PubMed ID: 25902484 [TBL] [Abstract][Full Text] [Related]
42. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Klein Wolterink RG; Kleinjan A; van Nimwegen M; Bergen I; de Bruijn M; Levani Y; Hendriks RW Eur J Immunol; 2012 May; 42(5):1106-16. PubMed ID: 22539286 [TBL] [Abstract][Full Text] [Related]
43. Nfil3 is required for the development of all innate lymphoid cell subsets. Seillet C; Rankin LC; Groom JR; Mielke LA; Tellier J; Chopin M; Huntington ND; Belz GT; Carotta S J Exp Med; 2014 Aug; 211(9):1733-40. PubMed ID: 25092873 [TBL] [Abstract][Full Text] [Related]
44. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871 [TBL] [Abstract][Full Text] [Related]
45. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962 [TBL] [Abstract][Full Text] [Related]
46. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells. Melo-Gonzalez F; Hepworth MR Immunology; 2017 Mar; 150(3):265-275. PubMed ID: 27935637 [TBL] [Abstract][Full Text] [Related]
48. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Li L; Zhang JA; Dose M; Kueh HY; Mosadeghi R; Gounari F; Rothenberg EV Blood; 2013 Aug; 122(6):902-11. PubMed ID: 23741008 [TBL] [Abstract][Full Text] [Related]
49. Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. Gold MJ; Antignano F; Halim TY; Hirota JA; Blanchet MR; Zaph C; Takei F; McNagny KM J Allergy Clin Immunol; 2014 Apr; 133(4):1142-8. PubMed ID: 24679471 [TBL] [Abstract][Full Text] [Related]
50. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Hoyler T; Klose CS; Souabni A; Turqueti-Neves A; Pfeifer D; Rawlins EL; Voehringer D; Busslinger M; Diefenbach A Immunity; 2012 Oct; 37(4):634-48. PubMed ID: 23063333 [TBL] [Abstract][Full Text] [Related]
52. Immunophenotyping of Human Innate Lymphoid Cells. Trabanelli S; Gomez-Cadena A; Jandus C Methods Mol Biol; 2019; 2032():179-192. PubMed ID: 31522419 [TBL] [Abstract][Full Text] [Related]
53. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway. Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786 [TBL] [Abstract][Full Text] [Related]
54. Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation. Morikawa T; Fukuoka A; Matsushita K; Yasuda K; Iwasaki N; Akasaki S; Fujieda S; Yoshimoto T Int Immunol; 2017 May; 29(5):221-233. PubMed ID: 28541554 [TBL] [Abstract][Full Text] [Related]
55. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Bal SM; Bernink JH; Nagasawa M; Groot J; Shikhagaie MM; Golebski K; van Drunen CM; Lutter R; Jonkers RE; Hombrink P; Bruchard M; Villaudy J; Munneke JM; Fokkens W; Erjefält JS; Spits H; Ros XR Nat Immunol; 2016 Jun; 17(6):636-45. PubMed ID: 27111145 [TBL] [Abstract][Full Text] [Related]
56. BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes. Cismasiu VB; Ghanta S; Duque J; Albu DI; Chen HM; Kasturi R; Avram D Blood; 2006 Oct; 108(8):2695-702. PubMed ID: 16809611 [TBL] [Abstract][Full Text] [Related]
57. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate. Thio CL; Chi PY; Lai AC; Chang YJ J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation. Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144 [TBL] [Abstract][Full Text] [Related]
59. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival. Uddin MN; Sultana DA; Lorentsen KJ; Cho JJ; Kirst ME; Brantly ML; Califano D; Sant'Angelo DB; Avram D Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7608-13. PubMed ID: 27330109 [TBL] [Abstract][Full Text] [Related]
60. Spred1, a Suppressor of the Ras-ERK Pathway, Negatively Regulates Expansion and Function of Group 2 Innate Lymphoid Cells. Suzuki M; Morita R; Hirata Y; Shichita T; Yoshimura A J Immunol; 2015 Aug; 195(3):1273-81. PubMed ID: 26116510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]